en

PRODUCT DETAIL

Fulvestrant STADA 250 mg

Code 1791E
MA number 34/0224/19-S
Product Form: sol iru 6x250 mg/5 ml (striek.skl.naplnená+6x ihla)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 34 - ANTIHORMONA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L02 ENDOCRINE THERAPY
L02B HORMONE ANTAGONISTS AND RELATED AGENTS
L02BA Anti-estrogens
L02BA03 Fulvestrant
Shelf life: 48
Container: glass pre-filled syringe
Route of admin.: Intramuscular use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.07.2019
Pediatric warnings: Yes
SPC: SPC_Fulvestrant STADA 250 mg sol iru_09_2023.pdf  
PIL: PIL_Fulvestrant STADA 250 mg sol iru_09_2023.pdf  
Safety feature Yes
Data update: 06.02.2024
eu-flag.png sk-flag.png